Accessibility Skip to Global Navigation Skip to Local Navigation Skip to Content Skip to Search Skip to Site Map Menu

Acute electrophysiological effects of Lithium on mouse olfactory bulb projection neurons in vitro

Lithium (Li+) has been used as a first-line drug in the treatment of bipolar disorder for more than six decades. Despite extensive research the therapeutic mechanism of action of Li+ remains unknown. A large body of recent evidence from genetic linkage, genome-wide association, and pathways-based analytical studies have implicated neuronal membrane ion channels in bipolar disorder. Evidence from few in vitro biophysical studies using Li+ have also indicated possible membrane effects of Li+, but no specific ion channel targets have been identified. In addition, selected antiepileptic drugs with established ion channel blocking effects are used as alternatives to or in combination with Li+, to treat bipolar disorder. Substantial evidence therefore suggests that bipolar disorder might be a ‘channelopathy’, and that Li+ might mediate its therapeutic effect by acting on membrane ion channels.
My study sought to identify possible post-synaptic membrane ion channel target(s) of Li+ in projection neurons within the limbic system, using olfactory bulb mitral cells as an in vitro model. My presentation will mainly focus on a prominent subthreshold membrane effect of Li+, mediated by blockade of a subthreshold K+ current similar to ID (the delay current defined in several types of brain neuron). It will also briefly address the role of glycogen synthase kinase-3 (GSK3) in Li+ action, and attempt to compare the effects of Li+ with other first-line bipolar drugs.

Date Wednesday, 14 November 2018
Time 3:00pm - 4:00pm
Audience All University
Event Category Health Sciences
Event Type
CampusDunedin
DepartmentPhysiology
LocationHercus d'Ath Lecture Theatre, Great King Street

Save this event